18 May 2021
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
Sponsored by ReCor Medical
Speaker:
A. Pathak
Summary
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering effectiveness at two months).
View the recording of this EuroPCR 2021 Session on "A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort".
Learning Objectives
- To learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system
- To hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering effectiveness at two months)